8IH
0.049
308.3%
BUY
0.002
-33.3%
PHO
0.12
41.2%
CNJ
0.008
-27.3%
PVT
0.031
40.9%
WBE
0.008
-20%
CVB
0.105
28%
FRX
0.009
-18.2%
ADG
0.014
27.3%
UNT
0.01
-16.7%
MRD
0.021
23.5%
REZ
0.016
-15.8%
FTI
0.17
21.4%
PLC
0.006
-14.3%
OEL
0.006
20%
TAT
0.042
-12.5%
MBH
0.115
19.8%
THR
0.014
-12.5%
CRN
0.34
17.2%
DTR
0.277
-12.1%
REE
0.042
16.7%
ALR
0.015
-11.8%
ATR
0.825
16.2%
EGR
0.575
-11.5%
FRE
0.074
15.6%
NVX
0.595
-11.2%
BEL
0.023
15%
TSL
0.008
-11.1%
G1C
0.069
15%
IPD
0.041
-10.9%
L1G
1.177
14.3%
KSN
0.125
-10.7%
AR9
0.092
13.6%
SOP
0.025
-10.7%
STG
0.35
12.9%
LRM
0.034
-10.5%
AAU
0.009
12.5%
GSS
0.305
-10.3%
5GG
0.028
12%
ANX
0.009
-10%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CYC Signed first U.S. contract with Duke University

Cyclopharm (ASX:CYC) announces the first signed U.S. contract for Technegas with Duke University Hospital following approval of by the USFDA on 29 September 2023 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231205/pdf/05y66m6jl37slv.pdf #CYC #USA #Technegas #shorts